Probing cationic selectivity of cardiac calsequestrin and its CPVT mutants

Biochemical Journal

Volumn 435, Issue 2, 2011, Pages 391-399

  Bal, Naresh C ^a   Jena, Nivedita ^a,c   Sopariwala, Danesh ^a   Balaraju, Tuniki ^b   Shaikh, Sana ^a   Bal, Chandralata ^b   Sharon, Ashoke ^b   Gyorke, Sandor ^a   Periasamy, Muthu ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Calcium binding protein; Calsequestrin; Catecholaminergic polymorphic ventricular tachycardia (CPVT); Metal ion; Molecular dynamics; Protein folding; Proteolysis

Indexed keywords

BARIUM ION; CALCIUM ION; CALSEQUESTRIN; COBALT; COPPER ION; DIVALENT CATION; MAGNESIUM ION; MANGANESE; METAL; MONOVALENT CATION; NICKEL; POTASSIUM ION; SILICON; SODIUM ION; ZINC ION;

ARTICLE; CALCIUM BINDING; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE; RAT;

AMINO ACID SEQUENCE; CALCIUM; CALSEQUESTRIN; CATIONS; HUMANS; METALS, ALKALINE EARTH; MODELS, MOLECULAR; MOLECULAR PROBE TECHNIQUES; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION, MISSENSE; MYOCARDIUM; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY; TACHYCARDIA, VENTRICULAR;

EID: 79953177849     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101771     Document Type: Article

References (46)

1. Bers, D. M. (2002) Cardiac excitation-contraction coupling. Nature 415, 198-205
2. Finney, L. A. and O'Halloran, T. V. (2003) Transition metal speciation in the cell: insights from the chemistry of metal ion receptors. Science 300, 931-936
3. Fedor, M. J. (2002) The role of metal ions in RNA catalysis. Curr. Opin. Struct. Biol. 12, 289-295
4. Luk, E., Jensen, L. T. and Culotta, V. C. (2003) The many highways for intracellular trafficking of metals. J. Biol. Inorg. Chem. 8, 803-809
5. Weber, K. T., Weglicki, W. B. and Simpson, R. U. (2009) Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc. Res. 81, 500-508
6. MacLennan, D. H. and Kranias, E. G. (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4, 566-577
7. 2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovasc. Res. 77, 265-273
8. Liu, N., Rizzi, N., Boveri, L. and Priori, S. G. (2009) Ryanodine receptor and calsequestrin in arrhythmogenesis: what we have learnt from genetic diseases and transgenic mice. J. Mol. Cell. Cardiol. 46, 149-159
9. Venetucci, L. A. and Eisner, D. A. (2008) Calsequestrin mutations and sudden death: a case of too little sarcoplasmic reticulum calcium buffering? Circ. Res. 103, 223-225
10. 2+ release: cytoplasmic and luminal regulation modeled in a tetrameric channel. J. Gen. Physiol. 132, 429-446
11. 2+ concentrations. Am. J. Physiol. Cell Physiol. 292, C535-C544
12. 2+ sites. Clin. Exp. Pharmacol. Physiol. 34, 889-896
13. Kurabayashi, M. (2005) Role of magnesium in cardiac metabolism. Clin. Calcium 15, 77-83
14. Kontula, K., Laitinen, P. J., Lehtonen, A., Toivonen, L., Viitasalo, M. and Swan, H. (2005) Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights. Cardiovasc. Res. 67, 379-387
15. 2+ ions on ryanodine binding to sarcoplasmic reticulum of striated muscles in the presence of pyrithione. Acta Pharmacol. Sin. 25, 1647-1651
16. Palmer, B. M., Vogt, S., Chen, Z., Lachapelle, R. R. and Lewinter, M. M. (2006) Intracellular distributions of essential elements in cardiomyocytes. J. Struct. Biol. 155, 12-21
17. 2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants. J. Gen. Physiol. 131, 325-334
18. 2+ cycling proteins. J. Mol. Cell. Cardiol. 34, 897-918
19. Wang, S., Trumble, W. R., Liao, H., Wesson, C. R., Dunker, A. K. and Kang, C. H. (1998) Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat. Struct. Biol. 5, 476-483
20. Park, H., Park, I. Y., Kim, E., Youn, B., Fields, K., Dunker, A. K. and Kang, C. (2004) Comparing skeletal and cardiac calsequestrin structures and their calcium binding: a proposed mechanism for coupled calcium binding and protein polymerization. J. Biol. Chem. 279, 18026-18033
21. 2+ regulation. J. Biol. Chem. 278, 16176-16182
22. Launikonis, B. S., Zhou, J., Royer, L., Shannon, T. R., Brum, G. and Rios, E. (2006) Depletion 'skraps' and dynamic buffering inside the cellular calcium store. Proc. Natl. Acad. Sci. U.S.A. 103, 2982-2987
23. Bal, N. C., Sharon, A., Gupta, S. C., Jena, N., Shaikh, S., Gyorke, S. and Periasamy, M. (2010) The catecholaminergic polymorphic ventricular tachycardia mutation R33Q disrupts the N-terminal structural motif that regulates reversible calsequestrin polymerization. J. Biol. Chem. 285, 17188-17196
24. Ikemoto, N., Nagy, B., Bhatnagar, G. M. and Gergely, J. (1974) Studies on a metal-binding protein of the sarcoplasmic reticulum. J. Biol. Chem. 249, 2357-2365
25. Rizzi, N., Liu, N., Napolitano, C., Nori, A., Turcato, F., Colombi, B., Bicciato, S., Arcelli, D., Spedito, A., Scelsi, M. et al. (2008) Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model. Circ. Res. 103, 298-306
26. Valle, G., Galla, D., Nori, A., Priori, S. G., Gyorke, S., de Filippis, V. and Volpe, P. (2008) Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin. Biochem. J. 413, 291-303
27. di Barletta, M. R., Viatchenko-Karpinski, S., Nori, A., Memmi, M., Terentyev, D., Turcato, F., Valle, G., Rizzi, N., Napolitano, C., Gyorke, S. et al. (2006) Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 114, 1012-1019 (Pubitemid 44358877)
28. Kim, E., Youn, B., Kemper, L., Campbell, C., Milting, H., Varsanyi, M. and Kang, C. (2007) Characterization of human cardiac calsequestrin and its deleterious mutants. J. Mol. Biol. 373, 1047-1057
29. Kalyanasundaram, A., Bal, N. C., Franzini-Armstrong, C., Knollmann, B. C. and Periasamy, M. (2010) The calsequestrin mutation CASQ2D307H does not affect protein stability and targeting to the junctional sarcoplasmic reticulum but compromises its dynamic regulation of calcium buffering. J. Biol. Chem. 285, 3076-3083
30. Lahat, H., Pras, E., Olender, T., Avidan, N., Ben-Asher, E., Man, O., Levy-Nissenbaum, E., Khoury, A., Lorber, A., Goldman, B., Lancet, D. and Eldar, M. (2001) A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am. J. Hum. Genet. 69, 1378-1384
31. 2+ handling and causes complex ventricular arrhythmias in mice. Cardiovasc. Res. 75, 69-78
32. de la Fuente, S., Van Langen, I. M., Postma, A. V., Bikker, H. and Meijer, A. (2008) A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations. Pacing Clin. Electrophysiol. 31, 916-919
33. Crooks, G. E., Hon, G., Chandonia, J. M. and Brenner, S. E. (2004) WebLogo: a sequence logo generator. Genome Res. 14, 1188-1190
34. Creighton, T. E. (1997) How important is the molten globule for correct protein folding? Trends. Biochem. Sci. 22, 6-10
35. Rose, G. D., Fleming, P. J., Banavar, J. R. and Maritan, A. (2006) A backbone-based theory of protein folding. Proc. Natl. Acad. Sci. U.S.A. 103, 16623-16633
36. Roca, M., Messer, B., Hilvert, D. and Warshel, A. (2008) On the relationship between folding and chemical landscapes in enzyme catalysis. Proc. Natl. Acad. Sci. U.S.A. 105, 13877-13882
37. Slupsky, J. R., Ohnishi, M., Carpenter, M. R. and Reithmeier, R. A. (1987) Characterization of cardiac calsequestrin. Biochemistry 26, 6539-6544
38. 1H NMR spectroscopy. J. Biol. Chem. 259, 11876-11881
39. 2+-induced folding and aggregation of skeletal muscle sarcoplasmic reticulum calsequestrin. The involvement of the trifluoperazine-binding site. J. Biol. Chem. 268, 24635-24641
40. Wei, L., Hanna, A. D., Beard, N. A. and Dulhunty, A. F. (2009) Unique isoform-specific properties of calsequestrin in the heart and skeletal muscle. Cell Calcium 45, 474-484
41. 2+-binding protein from sarcoplasmic reticulum. Arch. Biochem. Biophys. 251, 369-378
42. Mubagwa, K., Gwanyanya, A., Zakharov, S. and Macianskiene, R. (2007) Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium. Arch. Biochem. Biophys. 458, 73-89
43. 2+ and phosphorylation. Biophys. J. 88, 3444-3454
44. 2+ in cardiac myocytes. J. Gen. Physiol. 132, 721-730
45. Adamopoulos, C., Pitt, B., Sui, X., Love, T. E., Zannad, F. and Ahmed, A. (2009) Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study. Int. J. Cardiol. 136, 270-277
46. Ho, K. M. (2008) Intravenous magnesium for cardiac arrhythmias: jack of all trades. Magnes. Res. 21, 65-68